A GLUTATHIONE S-TRANSFEREASE P1 HAPLOTYPE ACTING IN MOTHERS DURING PREGNANCY MAY INCREASE RISK OF AUTISTIC DISORDER IN HER AFFECTED OFFSPRING

William Johnson; Edward Stenroos

A GLUTATHIONE S-TRANSFEREASE P1 HAPLOTYPE ACTING IN MOTHERS DURING PREGNANCY MAY INCREASE RISK OF AUTISTIC DISORDER IN HER AFFECTED OFFSPRING

William Johnson (Inventor), Edward Stenroos (Inventor)

Research output: Innovation

Abstract

Invention Summary: The present invention provides novel markers and assays for autism based on the association of a specific allele with prevalence for having a child or children with autism or autistic disease. The invention relates to the use and application of GSTP1 as a susceptibility marker and teratogenic allele for autism. In addition, the present invention discloses a novel method for identifying individuals who are genetically susceptible to have offspring with autism wherein the genotype of GSTP1, alone or in combination with other genetic markers or other indicators of oxidative stress, is determined. Market Applications: GSTP1 may be combined with other markers in methods and assays for monitoring, managing, diagnosis, prenatal diagnosis, and assessment of autism. Intellectual Property & Development Status: Published PCT Application: PCT/US2008/003052

Original language	American English
State	Published - Mar 2014

Keywords

Biomarkers
Genetics

Cite this

@misc{0bbc6e57f36745bbaf423afa0162ae19,

title = "A GLUTATHIONE S-TRANSFEREASE P1 HAPLOTYPE ACTING IN MOTHERS DURING PREGNANCY MAY INCREASE RISK OF AUTISTIC DISORDER IN HER AFFECTED OFFSPRING",

abstract = "Invention Summary: The present invention provides novel markers and assays for autism based on the association of a specific allele with prevalence for having a child or children with autism or autistic disease. The invention relates to the use and application of GSTP1 as a susceptibility marker and teratogenic allele for autism. In addition, the present invention discloses a novel method for identifying individuals who are genetically susceptible to have offspring with autism wherein the genotype of GSTP1, alone or in combination with other genetic markers or other indicators of oxidative stress, is determined. Market Applications: GSTP1 may be combined with other markers in methods and assays for monitoring, managing, diagnosis, prenatal diagnosis, and assessment of autism. Intellectual Property & Development Status: Published PCT Application: PCT/US2008/003052",

keywords = "Biomarkers, Genetics",

author = "William Johnson and Edward Stenroos",

year = "2014",

month = mar,

language = "American English",

type = "Patent",

}

TY - PAT

T1 - A GLUTATHIONE S-TRANSFEREASE P1 HAPLOTYPE ACTING IN MOTHERS DURING PREGNANCY MAY INCREASE RISK OF AUTISTIC DISORDER IN HER AFFECTED OFFSPRING

AU - Johnson, William

AU - Stenroos, Edward

PY - 2014/3

Y1 - 2014/3

N2 - Invention Summary: The present invention provides novel markers and assays for autism based on the association of a specific allele with prevalence for having a child or children with autism or autistic disease. The invention relates to the use and application of GSTP1 as a susceptibility marker and teratogenic allele for autism. In addition, the present invention discloses a novel method for identifying individuals who are genetically susceptible to have offspring with autism wherein the genotype of GSTP1, alone or in combination with other genetic markers or other indicators of oxidative stress, is determined. Market Applications: GSTP1 may be combined with other markers in methods and assays for monitoring, managing, diagnosis, prenatal diagnosis, and assessment of autism. Intellectual Property & Development Status: Published PCT Application: PCT/US2008/003052

AB - Invention Summary: The present invention provides novel markers and assays for autism based on the association of a specific allele with prevalence for having a child or children with autism or autistic disease. The invention relates to the use and application of GSTP1 as a susceptibility marker and teratogenic allele for autism. In addition, the present invention discloses a novel method for identifying individuals who are genetically susceptible to have offspring with autism wherein the genotype of GSTP1, alone or in combination with other genetic markers or other indicators of oxidative stress, is determined. Market Applications: GSTP1 may be combined with other markers in methods and assays for monitoring, managing, diagnosis, prenatal diagnosis, and assessment of autism. Intellectual Property & Development Status: Published PCT Application: PCT/US2008/003052

KW - Biomarkers

KW - Genetics

M3 - Innovation

ER -

A GLUTATHIONE S-TRANSFEREASE P1 HAPLOTYPE ACTING IN MOTHERS DURING PREGNANCY MAY INCREASE RISK OF AUTISTIC DISORDER IN HER AFFECTED OFFSPRING

Abstract

Keywords

Fingerprint

Cite this